Abstract OT1-01-11: Randomized phase 3 study of a novel, long-acting G-CSF (eflapegrastim) versus pegfilgrastim in the management of chemotherapy-induced neutropenia in early-stage breast cancer patients receiving docetaxel and cyclophosphamide (TC) (ADVANCE study)
2016 ◽
2014 ◽
Keyword(s):
2021 ◽
Vol 186
(2)
◽
pp. 585-586
Keyword(s):
Keyword(s):
2017 ◽
Vol 99
(2)
◽
pp. E36-E37
2009 ◽
Vol 75
(3)
◽
pp. S186
◽
2018 ◽
Vol 26
(4)
◽
pp. 945-953
◽